Developer docs
API playgroundTry for free, no card

Search company profiles

FutureHouse

Full company profile

uuid00eod3c

Namestring
FutureHouse
Legal namestring
Future House, Inc.
Websiteurl
futurehouse.org
Company typeenum
Private
Founded yearint
2023
Descriptiontext

FutureHouse is a 501(c)(3) nonprofit AI-for-science research lab founded in 2023 and headquartered in San Francisco, with a stated mission of building AI Scientists to automate and accelerate fundamental research in biology and adjacent complex sciences. The organization operates the AI-for-Science Independent Postdoctoral Fellowship as its flagship program, pairing early-career researchers with advanced AI tools and academic co-advisors at leading institutions including the Broad Institute, Stanford, Caltech, MIT, and Harvard. FutureHouse also publishes open research, releases open-source software, and offers a free self-paced tutorial series to help academic scientists integrate AI into their research workflows.

The technical portfolio centers on Robin, a multi-agent orchestration system that integrates specialized agents (Crow for literature synthesis, Falcon for chemical analysis, Finch for data analysis) to autonomously generate hypotheses, design experiments, analyze data, and validate findings. Supporting systems include PaperQA2, a retrieval-augmented generation agent that achieves expert-level performance on scientific literature tasks; DISCO, a multimodal diffusion model for simultaneous protein sequence and 3D structure design; OXtal, a generative model for organic crystal structure prediction; WikiCrow for automated scientific article synthesis; and the Aviary training framework for scientific language agents. FutureHouse has also released benchmarks (LAB-Bench, BixBench) that establish community evaluation standards. In May 2026, Robin's end-to-end autonomous discovery of ripasudil as a therapeutic candidate for dry AMD was published in Nature, marking the first validated AI-generated therapeutic hypothesis for a human disease.

FutureHouse generates no commercial product revenue and is funded entirely through philanthropic grants and donations. Initial two-year funding came from Eric and Wendy Schmidt, with additional support from OpenPhilanthropy, the National Science Foundation, and the AI Safety Institute. The organization accepts donations through its website and donor-advised funds and offers a Fellowship Sponsorship program for individuals and organizations wishing to support specific postdocs. A commercial counterpart, Edison Scientific, was spun out in 2023 to bring FutureHouse's AI research outputs to market under a separate governance structure, with the two entities sharing office space but operating independent missions.

Short descriptiontext

FutureHouse is a 501(c)(3) nonprofit AI research lab developing multi-agent systems, generative models, and benchmarks to automate scientific discovery in biology, serving academic researchers through postdoctoral fellowships and open-source tool releases.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI research agents, scientific discovery automation, multi-agent systems, computational biology research, AI for science
Industry3 codes
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHDAAAHAL
Scenario Planning, Forecasting Platforms & Planning Intelligence
NAICS code3 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Prepackaged Software7372
Product category
Scientific Discovery AI Software
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Philanthropic Funding
TypeData Monetisation
Description

FutureHouse is funded through grants and donations from foundations and philanthropists. Initial funding came from Eric and Wendy Schmidt for the first two years, with additional support from OpenPhilanthropy, National Science Foundation, and AI Safety Institute. The organization accepts donations through its website and donor advised funds.

futurehouse.org
2Fellowship Sponsorship
TypeData Monetisation
Description

Organizations and individuals can sponsor FutureHouse Fellows, providing resources for early-career scientists to conduct AI-accelerated research. Sponsors receive association with cutting-edge research but the nonprofit does not sell products or services.

futurehouse.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

FutureHouse is a 501(c)(3) nonprofit AI-for-science research lab that develops AI agents and multi-agent systems to automate scientific discovery in biology and complex sciences. Its portfolio includes Robin (a multi-agent orchestration system for end-to-end discovery), PaperQA/PaperQA2 (scientific literature RAG agent), DISCO (enzyme design model), OXtal (crystal structure prediction), and open benchmarks (LAB-Bench, BixBench, Aviary), all distributed openly to the scientific community alongside a postdoctoral fellowship program.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • A single day of AI Scientist can accomplish what human scientists accomplish in 6 months
+4 more records
Product overview1 text field

FutureHouse is a nonprofit AI-for-science research lab developing a portfolio of AI systems to automate and accelerate scientific discovery in biology. The core product is Robin, a multi-agent orchestration system that integrates specialized agents (Crow, Falcon, Finch) for end-to-end discovery from hypothesis to validation. Supporting products include PaperQA2 for literature synthesis, DISCO for protein design, and OXtal for crystal structure prediction. The portfolio also includes benchmarks (LAB-Bench, BixBench) and training frameworks (Aviary) for evaluating and developing scientific AI capabilities. The AI Scientist concept represents the overarching vision: a system that takes broad scientific questions and autonomously generates and validates novel discoveries.

Product and service11 records
1Robin Multi-Agent System
CategoryAI for Scientific Discovery
Description

Multi-agent AI system that autonomously generates hypotheses, designs experiments, analyzes data, and validates findings for end-to-end scientific discovery; built for academic and industry biology researchers.

2PaperQA / PaperQA2
CategoryAI for Scientific Discovery
Description

Retrieval-Augmented Generation agent for scientific literature that achieves expert-level performance on PubMedQA and other benchmarks by combining literature search, evidence gathering, and answer synthesis; available open-source on GitHub for researchers.

3FutureHouse AI Agent Platform (Crow, Owl, Falcon, Phoenix, Finch)
CategoryAI for Scientific Discovery
Description

Suite of specialized AI agents hosted on a web platform: Crow for literature synthesis, Owl for scientific literature search, Falcon for molecule evaluation, Phoenix for chemical synthesis design, and Finch for complex data analysis; built for biologists and chemistry researchers.

4DISCO (Diffusion for Sequence-structure CO-design)
CategoryGenerative Biology Model
Description

Multimodal generative model that simultaneously designs protein amino acid sequence and 3D structure co-folded with arbitrary biomolecules; used by enzyme designers and synthetic biology researchers for new-to-nature chemistry.

5OXtal
CategoryGenerative Chemistry Model
Description

100M-parameter all-atom diffusion model that predicts 3D organic crystal packings from 2D molecular graphs in seconds on a single GPU, replacing brute-force physics simulations; used by chemists and materials scientists.

6WikiCrow
CategoryAI for Scientific Discovery
Description

Automated system that synthesizes cited Wikipedia-style summaries from scientific literature for protein-coding genes; available open-source for the scientific community.

7LAB-Bench (Language Agent Biology Benchmark)
CategoryScientific AI Benchmark
Description

Benchmark of 2,457 questions across 8 categories that measures language model capabilities for biology research tasks such as literature extraction, database retrieval, sequence manipulation, and protocol design; available open-source.

8BixBench
CategoryScientific AI Benchmark
Description

Benchmark of 53 real-world bioinformatics analytical scenarios with 296 research questions that evaluates AI agents on autonomous data analysis and insight generation over biological datasets; available open-source.

9Aviary
CategoryScientific AI Training Framework
Description

Environment framework for training language agents on challenging scientific biology tasks, providing tools for protein engineering and literature summarization; available open-source.

10AI-for-Science Postdoctoral Fellowship
CategoryFellowship Program
Description

One-year postdoctoral fellowship (with possible extension) that pairs early-career scientists with FutureHouse AI tools, compute, engineering support, and academic co-advisors at leading institutions; intended for PhD graduates and postdocs pursuing AI-accelerated biology research.

11AI Tutorial Series
CategoryEducational Resource
Description

Free self-paced online tutorial series covering LLMs, agents, and practical AI implementation; targeted at scientists from non-computational backgrounds who want to integrate AI into research workflows.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Edison Scientific is the commercial spinout of FutureHouse, bringing the AI technology developed at FutureHouse to market. FutureHouse is a nonprofit focused on fundamental research for public good while Edison Scientific commercializes AI tools. The two organizations share office space but have separate missions, operations, and governance. FutureHouse has access to Edison's technology.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Fei Chen at Broad Institute serves as co-advisor for FutureHouse Fellow Blake Lash, who is developing AI tools to decode how parasitic worms suppress the human immune system.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Jesse Engreitz at Stanford University co-advises FutureHouse Fellow Philine Guckelberger, who is using AI to decode how 3D DNA structure controls gene activity in cancer.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Frances Arnold at Caltech serves as co-advisor for FutureHouse Fellow Chenghao Liu, who is building AI systems to design new enzymes. DISCO research collaboration involved Caltech researchers including Frances Arnold (co-author and Nobel laureate).

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Sergey Ovchinnikov at MIT serves as co-advisor for FutureHouse Fellow Sarah Gurev, who specializes in protein design and virology.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pardis Sabeti at Harvard co-advises FutureHouse Fellow Laura Luebbert, who is developing machine learning methods for infectious disease discovery.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

ScienceMachine partnered with FutureHouse to develop BixBench, a benchmark for evaluating AI agents on bioinformatics tasks.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

AI research lab developing frontier foundation models for biology, including protein language models. Emerging player with comparable focus on AI-native biological discovery.

TypeDirect peer
Description

AI-driven drug discovery company that uses generative AI and reinforcement learning to identify novel targets and design molecules. Competes with FutureHouse in end-to-end AI-driven therapeutic discovery.

TypeBroad incumbent
Description

Frontier AI research lab with significant investment in scientific applications including AlphaFold, AlphaMissense, and other biology-focused AI systems. Broad incumbent that could subsume many of FutureHouse's capabilities.

TypeDirect peer
Description

TechBio company combining high-throughput biology with AI/ML to discover medicines at scale. Competes with FutureHouse in applying AI to industrial-scale drug discovery and biology research.

TypeBroad incumbent
Description

Frontier AI lab with general-purpose models increasingly applied to scientific reasoning and literature analysis. Broad incumbent with potential to compete in scientific agent capabilities.

TypeOthers
Description

Nonprofit AI research institute (Semantic Scholar partner of FutureHouse) that develops open AI models and scientific literature tools. Thematically aligned nonprofit AI-for-science peer and ecosystem partner.

TypeEmerging player
Description

AI protein design company using generative models to engineer novel proteins for biotech applications. Direct overlap with FutureHouse's DISCO multimodal generative model for protein sequence and structure co-design.

8Isomorphic Labs
TypeDirect peer
Description

Alphabet/Google DeepMind subsidiary applying AI to drug discovery and biomedical research. Builds AlphaFold-derived platforms for protein structure prediction and therapeutic design, directly overlapping with FutureHouse's Robin, DISCO, and OXtal capabilities.

TypeDirect peer
Description

AI-driven small molecule drug design company using structure-based deep learning models. Comparable to FutureHouse's DISCO and OXtal for protein/crystal design and small molecule discovery.

TypeDirect peer
Description

Commercial spinout of FutureHouse that commercializes the AI tools developed at the nonprofit, including scientific discovery agents. Shares office space and has access to FutureHouse's research, but operates independently with a for-profit mission.

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

FutureHouse

Scientific Discovery AI Softwarefuturehouse.org

FutureHouse is a 501(c)(3) nonprofit AI research lab developing multi-agent systems, generative models, and benchmarks to automate scientific discovery in biology, serving academic researchers through postdoctoral fellowships and open-source tool releases.

What FutureHouse does

FutureHouse is a 501(c)(3) nonprofit AI-for-science research lab founded in 2023 and headquartered in San Francisco, with a stated mission of building AI Scientists to automate and accelerate fundamental research in biology and adjacent complex sciences. The organization operates the AI-for-Science Independent Postdoctoral Fellowship as its flagship program, pairing early-career researchers with advanced AI tools and academic co-advisors at leading institutions including the Broad Institute, Stanford, Caltech, MIT, and Harvard. FutureHouse also publishes open research, releases open-source software, and offers a free self-paced tutorial series to help academic scientists integrate AI into their research workflows.

The technical portfolio centers on Robin, a multi-agent orchestration system that integrates specialized agents (Crow for literature synthesis, Falcon for chemical analysis, Finch for data analysis) to autonomously generate hypotheses, design experiments, analyze data, and validate findings. Supporting systems include PaperQA2, a retrieval-augmented generation agent that achieves expert-level performance on scientific literature tasks; DISCO, a multimodal diffusion model for simultaneous protein sequence and 3D structure design; OXtal, a generative model for organic crystal structure prediction; WikiCrow for automated scientific article synthesis; and the Aviary training framework for scientific language agents. FutureHouse has also released benchmarks (LAB-Bench, BixBench) that establish community evaluation standards. In May 2026, Robin's end-to-end autonomous discovery of ripasudil as a therapeutic candidate for dry AMD was published in Nature, marking the first validated AI-generated therapeutic hypothesis for a human disease.

FutureHouse generates no commercial product revenue and is funded entirely through philanthropic grants and donations. Initial two-year funding came from Eric and Wendy Schmidt, with additional support from OpenPhilanthropy, the National Science Foundation, and the AI Safety Institute. The organization accepts donations through its website and donor-advised funds and offers a Fellowship Sponsorship program for individuals and organizations wishing to support specific postdocs. A commercial counterpart, Edison Scientific, was spun out in 2023 to bring FutureHouse's AI research outputs to market under a separate governance structure, with the two entities sharing office space but operating independent missions.

FutureHouse firmographics

Firmographics
Name
FutureHouse
Legal name
Future House, Inc.
Website
https://futurehouse.org
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
1–10 employees
Short description
FutureHouse is a 501(c)(3) nonprofit AI research lab developing multi-agent systems, generative models, and benchmarks to automate scientific discovery in biology, serving academic researchers through postdoctoral fellowships and open-source tool releases.
Ownership category
akta.pro rank

FutureHouse industry classification

Industry
Product category
Scientific Discovery AI Software
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAC
Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHDAAAHAL
Scenario Planning, Forecasting Platforms & Planning Intelligence

Keywords

  • AI research agents
  • Scientific discovery automation
  • Multi-agent systems
  • Computational biology research
  • AI for science

Where FutureHouse is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

FutureHouse business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Philanthropic Funding: FutureHouse is funded through grants and donations from foundations and philanthropists. Initial funding came from Eric and Wendy Schmidt for the first two years, with additional support from OpenPhilanthropy, National Science Foundation, and AI Safety Institute. The organization accepts donations through its website and donor advised funds.
  2. Fellowship Sponsorship: Organizations and individuals can sponsor FutureHouse Fellows, providing resources for early-career scientists to conduct AI-accelerated research. Sponsors receive association with cutting-edge research but the nonprofit does not sell products or services.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels7 records

FutureHouse product offering

Product offering

Core offering

FutureHouse is a 501(c)(3) nonprofit AI-for-science research lab that develops AI agents and multi-agent systems to automate scientific discovery in biology and complex sciences. Its portfolio includes Robin (a multi-agent orchestration system for end-to-end discovery), PaperQA/PaperQA2 (scientific literature RAG agent), DISCO (enzyme design model), OXtal (crystal structure prediction), and open benchmarks (LAB-Bench, BixBench, Aviary), all distributed openly to the scientific community alongside a postdoctoral fellowship program.

Product overview

FutureHouse is a nonprofit AI-for-science research lab developing a portfolio of AI systems to automate and accelerate scientific discovery in biology. The core product is Robin, a multi-agent orchestration system that integrates specialized agents (Crow, Falcon, Finch) for end-to-end discovery from hypothesis to validation. Supporting products include PaperQA2 for literature synthesis, DISCO for protein design, and OXtal for crystal structure prediction. The portfolio also includes benchmarks (LAB-Bench, BixBench) and training frameworks (Aviary) for evaluating and developing scientific AI capabilities. The AI Scientist concept represents the overarching vision: a system that takes broad scientific questions and autonomously generates and validates novel discoveries.

Differentiator

Problem solved

Functional benefit

Products and services

  • Robin Multi-Agent System Multi-agent AI system that autonomously generates hypotheses, designs experiments, analyzes data, and validates findings for end-to-end scientific discovery; built for academic and industry biology researchers.
  • PaperQA / PaperQA2 Retrieval-Augmented Generation agent for scientific literature that achieves expert-level performance on PubMedQA and other benchmarks by combining literature search, evidence gathering, and answer synthesis; available open-source on GitHub for researchers.
  • FutureHouse AI Agent Platform (Crow, Owl, Falcon, Phoenix, Finch) Suite of specialized AI agents hosted on a web platform: Crow for literature synthesis, Owl for scientific literature search, Falcon for molecule evaluation, Phoenix for chemical synthesis design, and Finch for complex data analysis; built for biologists and chemistry researchers.
  • DISCO (Diffusion for Sequence-structure CO-design) Multimodal generative model that simultaneously designs protein amino acid sequence and 3D structure co-folded with arbitrary biomolecules; used by enzyme designers and synthetic biology researchers for new-to-nature chemistry.
  • OXtal 100M-parameter all-atom diffusion model that predicts 3D organic crystal packings from 2D molecular graphs in seconds on a single GPU, replacing brute-force physics simulations; used by chemists and materials scientists.
  • WikiCrow Automated system that synthesizes cited Wikipedia-style summaries from scientific literature for protein-coding genes; available open-source for the scientific community.
  • LAB-Bench (Language Agent Biology Benchmark) Benchmark of 2,457 questions across 8 categories that measures language model capabilities for biology research tasks such as literature extraction, database retrieval, sequence manipulation, and protocol design; available open-source.
  • BixBench Benchmark of 53 real-world bioinformatics analytical scenarios with 296 research questions that evaluates AI agents on autonomous data analysis and insight generation over biological datasets; available open-source.
  • Aviary Environment framework for training language agents on challenging scientific biology tasks, providing tools for protein engineering and literature summarization; available open-source.
  • AI-for-Science Postdoctoral Fellowship One-year postdoctoral fellowship (with possible extension) that pairs early-career scientists with FutureHouse AI tools, compute, engineering support, and academic co-advisors at leading institutions; intended for PhD graduates and postdocs pursuing AI-accelerated biology research.
  • AI Tutorial Series Free self-paced online tutorial series covering LLMs, agents, and practical AI implementation; targeted at scientists from non-computational backgrounds who want to integrate AI into research workflows.

Quantifiable outcome

  • A single day of AI Scientist can accomplish what human scientists accomplish in 6 months
  • +4 more outcomes

Companies that use FutureHouse

Customer profile

Segments3 records

Ideal customer profiles3 records

FutureHouse technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability9 records

Feature10 records

FutureHouse partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • Edison ScientificcoreStrategic or Co-development Partner · 1 January 2023Edison Scientific is the commercial spinout of FutureHouse, bringing the AI technology developed at FutureHouse to market. FutureHouse is a nonprofit focused on fundamental research for public good while Edison Scientific commercializes AI tools. The two organizations share office space but have separate missions, operations, and governance. FutureHouse has access to Edison's technology.
  • Broad InstitutecoreStrategic or Co-development PartnerFei Chen at Broad Institute serves as co-advisor for FutureHouse Fellow Blake Lash, who is developing AI tools to decode how parasitic worms suppress the human immune system.
  • Stanford UniversitycoreStrategic or Co-development PartnerJesse Engreitz at Stanford University co-advises FutureHouse Fellow Philine Guckelberger, who is using AI to decode how 3D DNA structure controls gene activity in cancer.
  • California Institute of Technology (Caltech)coreStrategic or Co-development PartnerFrances Arnold at Caltech serves as co-advisor for FutureHouse Fellow Chenghao Liu, who is building AI systems to design new enzymes. DISCO research collaboration involved Caltech researchers including Frances Arnold (co-author and Nobel laureate).
  • Massachusetts Institute of Technology (MIT)coreStrategic or Co-development PartnerSergey Ovchinnikov at MIT serves as co-advisor for FutureHouse Fellow Sarah Gurev, who specializes in protein design and virology.
  • Harvard T.H. Chan School of Public HealthcoreStrategic or Co-development PartnerPardis Sabeti at Harvard co-advises FutureHouse Fellow Laura Luebbert, who is developing machine learning methods for infectious disease discovery.
  • ScienceMachineminorStrategic or Co-development PartnerScienceMachine partnered with FutureHouse to develop BixBench, a benchmark for evaluating AI agents on bioinformatics tasks.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

FutureHouse competitors and assessment

Company assessment

Emerging players

  • EvolutionaryScale: AI research lab developing frontier foundation models for biology, including protein language models. Emerging player with comparable focus on AI-native biological discovery.
  • Cradle Bio: AI protein design company using generative models to engineer novel proteins for biotech applications. Direct overlap with FutureHouse's DISCO multimodal generative model for protein sequence and structure co-design.

Direct peers

  • Insilico Medicine: AI-driven drug discovery company that uses generative AI and reinforcement learning to identify novel targets and design molecules. Competes with FutureHouse in end-to-end AI-driven therapeutic discovery.
  • Recursion Pharmaceuticals: TechBio company combining high-throughput biology with AI/ML to discover medicines at scale. Competes with FutureHouse in applying AI to industrial-scale drug discovery and biology research.
  • Isomorphic Labs: Alphabet/Google DeepMind subsidiary applying AI to drug discovery and biomedical research. Builds AlphaFold-derived platforms for protein structure prediction and therapeutic design, directly overlapping with FutureHouse's Robin, DISCO, and OXtal capabilities.
  • Atomwise: AI-driven small molecule drug design company using structure-based deep learning models. Comparable to FutureHouse's DISCO and OXtal for protein/crystal design and small molecule discovery.
  • Edison Scientific: Commercial spinout of FutureHouse that commercializes the AI tools developed at the nonprofit, including scientific discovery agents. Shares office space and has access to FutureHouse's research, but operates independently with a for-profit mission.

Broad incumbents

  • Google DeepMind: Frontier AI research lab with significant investment in scientific applications including AlphaFold, AlphaMissense, and other biology-focused AI systems. Broad incumbent that could subsume many of FutureHouse's capabilities.
  • Anthropic: Frontier AI lab with general-purpose models increasingly applied to scientific reasoning and literature analysis. Broad incumbent with potential to compete in scientific agent capabilities.

Others

  • Allen Institute for AI (AI2): Nonprofit AI research institute (Semantic Scholar partner of FutureHouse) that develops open AI models and scientific literature tools. Thematically aligned nonprofit AI-for-science peer and ecosystem partner.

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

FutureHouse social profiles

Digital presence

FutureHouse financial estimates

Financial estimate

Revenue estimate

Valuation estimate

FutureHouse leadership team

Management profile

Number of profiles

Profiles4 records

FutureHouse funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

FutureHouse M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FutureHouse

What does FutureHouse do?

FutureHouse is a 501(c)(3) nonprofit AI-for-science research lab that develops AI agents and multi-agent systems to automate scientific discovery in biology and complex sciences. Its portfolio includes Robin (a multi-agent orchestration system for end-to-end discovery), PaperQA/PaperQA2 (scientific literature RAG agent), DISCO (enzyme design model), OXtal (crystal structure prediction), and open benchmarks (LAB-Bench, BixBench, Aviary), all distributed openly to the scientific community alongside a postdoctoral fellowship program.

Is FutureHouse a public or private company?

FutureHouse is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was FutureHouse founded?

FutureHouse was founded in 2023. It employs 1 to 10 people.

Where is FutureHouse based?

FutureHouse is headquartered in San Francisco, United States, in the North America region.

How does FutureHouse make money?

Two revenue lines are on record. Philanthropic Funding is the primary driver. The others are fellowship Sponsorship.

Who are FutureHouse's main competitors?

Emerging players on record are EvolutionaryScale and Cradle Bio. Direct peers are Insilico Medicine, Recursion Pharmaceuticals, Isomorphic Labs, Atomwise and Edison Scientific. Broad incumbents are Google DeepMind and Anthropic. Allen Institute for AI (AI2) is listed as an others.

Does FutureHouse have an API?

No public API is recorded for FutureHouse.

What industry is FutureHouse in?

FutureHouse's product category is Scientific Discovery AI Software. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAGAJAC, Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D). Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
WikipediaHumanity's Last ExamHumanity's Last Exam is a 2,500-question benchmark released in January 2025 by the Center for AI Safety and Scale AI. It includes graduate-level questions across subjects, with 24% multiple-choice and 14% multi-modal. A FutureHouse investigation found about 30% of chemistry and biology answers incorrect, prompting a rolling update.BioSpaceBiopharma R&D needs ‘structural redesign’ to maximize AI impact: reportManagement consultancy McKinsey has released a report arguing that biopharma companies must fundamentally reorganize their R&D units around a closed-loop model with five connected decision points to fully capture AI benefits, as applying AI to current linear stage-gate workflows only improves individual steps without compounding learning. The report comes amid a surge in AI drug development deals, with Eli Lilly, Bristol Myers Squibb, Incyte, Alnylam, and Merck announcing partnerships in recent months, and Alphabet's Isomorphic Labs raising $2.1 billion in May. McKinsey proposes that closed-loop systems—exemplified by companies like Recursion Pharmaceuticals and tools such as FutureHouse's Robin and Google DeepMind's Co-Scientist—can continuously feed data from each decision point back into prior and subsequent stages to compress trial duration and decision cycles.Singularity HubAI Lab Partners Are Rewiring the Hunt for New DrugsThe article reports on two AI systems, Robin by FutureHouse and Co-Scientist by Google DeepMind, used to accelerate drug discovery by collaborating with scientists. Robin identified promising drugs for eye conditions, while Co-Scientist found candidates for liver scarring and other diseases, demonstrating significant reductions in research time.Ars TechnicaTwo AI-based science assistants succeed with drug-retargeting tasksGoogle's Co-Scientist and FutureHouse's Robin are AI systems that generate drug-retargeting hypotheses. Co-Scientist identified drugs effective against subsets of myeloid leukemia cells, while Robin suggested a drug that boosted retinal debris uptake in macular degeneration models. Both systems rely on literature search tools and human expert evaluation.Chemical & Engineering NewsAI companies introduce new agent-based tools for scientific discoveryAI companies Google DeepMind and FutureHouse have introduced new agent-based tools, Co-Scientist and Robin, designed to assist researchers in generating hypotheses, designing experiments, and analyzing data. These tools aim to enhance drug repurposing efforts using already approved FDA drugs, while acknowledging limitations in their ability to produce truly novel insights. The development signifies a growing trend of integrating AI systems into scientific research to accelerate discovery processes.UndarkWhat the Rise of AI Scientists May Mean for Human ResearchAI systems such as Carl, Robin, and Kosmos are increasingly being used to conduct scientific research, with companies like Autoscience Institute, FutureHouse, and Sakana AI developing agents capable of generating hypotheses and analyzing data. While these tools offer potential efficiency gains in fields like materials science, they have also raised concerns regarding data integrity, methodological flaws, and the displacement of human researchers.GeneOnline NewsFutureHouse Develops Kosmos AI System to Address Drug Development DelaysFutureHouse has developed the Kosmos AI system to address delays in drug development. The system aims to streamline data analysis and discovery processes in medical research.VoxHow AI could reboot science and revive long-term economic growthThe article argues that artificial intelligence can revitalize long-term economic growth by serving as an infrastructure for scientific research, helping researchers process vast amounts of data and accelerate discoveries in fields like drug repurposing and material science. It highlights specific AI tools such as DeepMind's AlphaFold and GraphCast, as well as platforms from FutureHouse and Carnegie Mellon, which automate literature reviews and experimental design to enhance productivity. The author contends that leveraging AI for science offers a more constructive path forward than the prevalent societal anxiety or calls for regulation surrounding the technology.36krAI Achieves in Half a Day What a Doctoral Student Needs Six Months for, Causing a Huge Shock in Biochemistry Circle and Ultraman's Extreme ExcitementFutureHouse, a non-profit AI research organization backed by OpenAI, has unveiled Kosmos, an AI scientist system capable of completing in a single run what would take a doctoral researcher approximately six months, including reading 1,500 papers and executing 42,000 lines of analysis code, with an independently verified accuracy rate of 79.4%. Kosmos independently replicated three major discoveries in neuroscience, materials science, and biology, and made four original discoveries in genetic epidemiology, multi-omics integration, Alzheimer's disease, and transcriptomics. OpenAI CEO Sam Altman publicly celebrated the achievement, calling it one of the most profound impacts of AI and reinforcing OpenAI's stated goal of achieving an intern-level research AI by 2026.